James Gordon analyst BAML

Currently out of the existing stock ratings of James Gordon, 23 are a BUY (36.51%), 38 are a HOLD (60.32%), 2 are a SELL (3.17%).

James Gordon

Work Performance Price Targets & Ratings Chart

Analyst James Gordon, currently employed at BAML, carries an average stock price target met ratio of 59.68% that have a potential upside of 28.99% achieved within 212 days.

James Gordon’s has documented 125 price targets and ratings displayed on 9 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on ARGX, argenx NV ADR at 04-Nov-2024.

Wall Street Analyst James Gordon

Analyst best performing recommendations are on GRFS (GRIFOLS SA ADR).
The best stock recommendation documented was for GRFS (GRIFOLS SA ADR) at 1/3/2023. The price target of $9.09 was fulfilled within 1 day with a profit of $0.35 (4%) receiving and performance score of 40.05.

Average potential price target upside

ALC Alcon AG ARGX argenx NV ADR GLPG Galapagos NV ADR GMAB Genmab AS GSK GlaxoSmithKline PLC ADR GRFS Grifols SA ADR MOR MorphoSys AG ADR AZN AstraZeneca PLC ADR ABCM Abcam PLC

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$108

$23.24 (27.42%)

$103

9 days ago
(17-Dec-2024)

14/22 (63.64%)

$22.55 (26.39%)

334

Buy

$106

$21.24 (25.06%)

$104

2 months 12 days ago
(14-Oct-2024)

9/11 (81.82%)

$8.8 (9.05%)

91

Buy

$110

$25.24 (29.78%)

$104

4 months 4 days ago
(22-Aug-2024)

7/9 (77.78%)

$14.67 (15.39%)

282

Buy

$105

$20.24 (23.88%)

$100

7 months 11 days ago
(15-May-2024)

11/12 (91.67%)

$15.03 (16.71%)

311

Buy

$100

$15.24 (17.98%)

$90

9 months 22 days ago
(04-Mar-2024)

6/6 (100%)

$13.26 (15.29%)

297

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is James Gordon is most bullish on?

Potential upside of $46.18 has been obtained for ARGX (ARGENX NV ADR)

What Year was the first public recommendation made by James Gordon?

On 2017

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?